Nadhem Abdallah MD, Mohammed Samra MD, Momen Alsayed MBBS
{"title":"完全房室传导阻滞的住院和再入院结果的性别差异:来自美国再入院数据的见解","authors":"Nadhem Abdallah MD, Mohammed Samra MD, Momen Alsayed MBBS","doi":"10.1002/joa3.70013","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Sex disparities in cardiovascular disorders are well-documented, but data on hospitalization and readmission outcomes in the context of sex for Complete Heart Block (CHB) remains limited.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We analyzed the 2016–2020 Nationwide Readmission Database to identify patients with a principal diagnosis of CHB. Men served as the control group, while women comprised the study cohort. The primary outcome was mortality. Secondary outcomes included odds of cardiac arrest, ventricular tachycardia, heart failure, mechanical ventilation use, all-cause 30-day readmission, total and early pacemaker use, length of stay (LOS), and total hospitalization charges (THC). Multivariate regression models adjusted for confounders.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 175,257 patients with CHB, 45% were female. Female sex was associated with higher odds of mortality (adjusted OR [aOR] 1.42, 95% CI 1.3–1.55) compared to males. Additionally, females had higher odds of cardiac arrest (aOR 1.13, 95% CI 1.06–1.2), ventricular tachycardia (aOR 1.1, 95% CI 1.05–1.17), heart failure (aOR 1.18, 95% CI 1.14–1.22), mechanical ventilation use (aOR 1.1, 95% CI 1.03–1.17), and all-cause 30-day readmission (aOR 1.1, 95% CI 1.03–1.14). Women also had lower odds of total pacemaker use (aOR 0.92, 95% CI 0.88–0.96) and early pacemaker use (aOR 0.89, 95% CI 0.86–0.82). Female patients exhibited longer LOS (4.13 days vs. 3.86 days, <i>p</i> < 0.001) but incurred lower THC ($89,908 vs. $94,590, <i>p</i> = 0.002).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Female sex in CHB patients was associated with higher mortality and adverse events but lower pacemaker use compared to male patients.</p>\n </section>\n </div>","PeriodicalId":15174,"journal":{"name":"Journal of Arrhythmia","volume":"41 1","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/joa3.70013","citationCount":"0","resultStr":"{\"title\":\"Sex based disparities in hospitalization and readmission outcomes for complete atrioventricular block: Insights from United States readmission data\",\"authors\":\"Nadhem Abdallah MD, Mohammed Samra MD, Momen Alsayed MBBS\",\"doi\":\"10.1002/joa3.70013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Sex disparities in cardiovascular disorders are well-documented, but data on hospitalization and readmission outcomes in the context of sex for Complete Heart Block (CHB) remains limited.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We analyzed the 2016–2020 Nationwide Readmission Database to identify patients with a principal diagnosis of CHB. Men served as the control group, while women comprised the study cohort. The primary outcome was mortality. Secondary outcomes included odds of cardiac arrest, ventricular tachycardia, heart failure, mechanical ventilation use, all-cause 30-day readmission, total and early pacemaker use, length of stay (LOS), and total hospitalization charges (THC). Multivariate regression models adjusted for confounders.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Among 175,257 patients with CHB, 45% were female. Female sex was associated with higher odds of mortality (adjusted OR [aOR] 1.42, 95% CI 1.3–1.55) compared to males. Additionally, females had higher odds of cardiac arrest (aOR 1.13, 95% CI 1.06–1.2), ventricular tachycardia (aOR 1.1, 95% CI 1.05–1.17), heart failure (aOR 1.18, 95% CI 1.14–1.22), mechanical ventilation use (aOR 1.1, 95% CI 1.03–1.17), and all-cause 30-day readmission (aOR 1.1, 95% CI 1.03–1.14). Women also had lower odds of total pacemaker use (aOR 0.92, 95% CI 0.88–0.96) and early pacemaker use (aOR 0.89, 95% CI 0.86–0.82). Female patients exhibited longer LOS (4.13 days vs. 3.86 days, <i>p</i> < 0.001) but incurred lower THC ($89,908 vs. $94,590, <i>p</i> = 0.002).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Female sex in CHB patients was associated with higher mortality and adverse events but lower pacemaker use compared to male patients.</p>\\n </section>\\n </div>\",\"PeriodicalId\":15174,\"journal\":{\"name\":\"Journal of Arrhythmia\",\"volume\":\"41 1\",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/joa3.70013\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Arrhythmia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/joa3.70013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arrhythmia","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/joa3.70013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:心血管疾病的性别差异已被充分记录,但完全心脏传导阻滞(CHB)在性别背景下的住院和再入院结果数据仍然有限。方法分析2016-2020年全国再入院数据库,以确定主要诊断为CHB的患者。男性作为对照组,而女性则组成研究队列。主要结局是死亡率。次要结局包括心脏骤停、室性心动过速、心力衰竭、机械通气使用、全因30天再入院、总起搏器和早期起搏器使用、住院时间(LOS)和总住院费用(THC)。校正混杂因素的多元回归模型。结果175,257例慢性乙型肝炎患者中,女性占45%。与男性相比,女性与更高的死亡率相关(校正OR [aOR] 1.42, 95% CI 1.3-1.55)。此外,女性心脏骤停(aOR 1.13, 95% CI 1.06-1.2)、室性心动过速(aOR 1.1, 95% CI 1.05-1.17)、心力衰竭(aOR 1.18, 95% CI 1.14-1.22)、机械通气使用(aOR 1.1, 95% CI 1.03-1.17)和全因30天再入院(aOR 1.1, 95% CI 1.03-1.14)的几率更高。女性使用总起搏器(aOR 0.92, 95% CI 0.88-0.96)和早期使用起搏器(aOR 0.89, 95% CI 0.86-0.82)的几率也较低。女性患者表现出较长的LOS(4.13天对3.86天,p < 0.001),但THC较低(89,908美元对94,590美元,p = 0.002)。结论女性CHB患者死亡率和不良事件较高,但起搏器使用率较男性低。
Sex based disparities in hospitalization and readmission outcomes for complete atrioventricular block: Insights from United States readmission data
Background
Sex disparities in cardiovascular disorders are well-documented, but data on hospitalization and readmission outcomes in the context of sex for Complete Heart Block (CHB) remains limited.
Methods
We analyzed the 2016–2020 Nationwide Readmission Database to identify patients with a principal diagnosis of CHB. Men served as the control group, while women comprised the study cohort. The primary outcome was mortality. Secondary outcomes included odds of cardiac arrest, ventricular tachycardia, heart failure, mechanical ventilation use, all-cause 30-day readmission, total and early pacemaker use, length of stay (LOS), and total hospitalization charges (THC). Multivariate regression models adjusted for confounders.
Results
Among 175,257 patients with CHB, 45% were female. Female sex was associated with higher odds of mortality (adjusted OR [aOR] 1.42, 95% CI 1.3–1.55) compared to males. Additionally, females had higher odds of cardiac arrest (aOR 1.13, 95% CI 1.06–1.2), ventricular tachycardia (aOR 1.1, 95% CI 1.05–1.17), heart failure (aOR 1.18, 95% CI 1.14–1.22), mechanical ventilation use (aOR 1.1, 95% CI 1.03–1.17), and all-cause 30-day readmission (aOR 1.1, 95% CI 1.03–1.14). Women also had lower odds of total pacemaker use (aOR 0.92, 95% CI 0.88–0.96) and early pacemaker use (aOR 0.89, 95% CI 0.86–0.82). Female patients exhibited longer LOS (4.13 days vs. 3.86 days, p < 0.001) but incurred lower THC ($89,908 vs. $94,590, p = 0.002).
Conclusion
Female sex in CHB patients was associated with higher mortality and adverse events but lower pacemaker use compared to male patients.